TY  - GEN
AU  - Piccart,M J
AU  - Bertelsen,K
AU  - Stuart,G
AU  - Cassidy,J
AU  - Mangioni,C
AU  - Simonsen,E
AU  - James,K
AU  - Kaye,S
AU  - Vergote,I
AU  - Blom,R
AU  - Grimshaw,R
AU  - Atkinson,R
AU  - Swenerton,K
AU  - Trope,C
AU  - Nardi,M
AU  - Kaern,J
AU  - Tumolo,S
AU  - Timmers,P
AU  - Roy,J-A
AU  - Lhoas,F
AU  - Lidvall,B
AU  - Bacon,M
AU  - Birt,A
AU  - Andersen,J
AU  - Zee,B
AU  - Paul,J
AU  - Pecorelli,S
AU  - Baron,B
AU  - McGuire,W
TI  - Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
SN  - 1048-891X
PY  - 2004///0408
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Canada
KW  - Cisplatin
KW  - administration & dosage
KW  - Cyclophosphamide
KW  - Europe
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Longitudinal Studies
KW  - Neoplasm Staging
KW  - Ovarian Neoplasms
KW  - drug therapy
KW  - Paclitaxel
KW  - Randomized Controlled Trials as Topic
KW  - Survival Analysis
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1111/j.1525-1438.2003.13357.x
ER  -